Main > A1. CORP. INDEX. B-Bm > BioGen./P C2

---

This data is not available for free

BioGen./P C2's subsections
2006. 06.06.2006. Onco.>Lymphoma
2007. 11.16.2007. GI.>Crohns Dis.
2007. 11.20.2007. Neuro.>AD
2008. 02.29.2008. Debt Bonds
2008. 03.24.2008. Neublastin
2010. 02.18.2010. Onco.>CLL
2010. 03.22.2010. BoD
2010. 05.19.2010. RA>OcrelizuMAb
2010. 06.30.2010. CEO
2010. 08.18.2010. Neuro.>ALS
2010. 10.06.2010. Neuro.>MS>Present
2010. 10.21.2010. CD20MAb/Genentech
2010. 11.03.2010. CardioKine Inc.
2010. 12.20.2010. NeurImmune
2011. 01.05.2011. Head R&D &
2011. 08.09.2011. Neuro.>MS>MAb>D
2011. 09.06.2011. BioGen Dompé JV
2011. 09.29.2011. VP Global Comm..
2011. 10.27.2011. Portola Pharma.
2011. 12.05.2011. Samsung
2012. 01.04.2012. Isis Pharma.
2012. 01.30.2012. Ex VP Human Res.
2012. 02.27.2012. Samsung Biologics
2012. 02.28.2012. Neuro.>MS>IFN
2012. 04.11.2012. Neuro.>MS>Walk.
2012. 06.29.2012. Isis Pharma.
2012. 07.17.2012. Neuro.>ALS Seq.
2012. 09.10.2012. DRI Capital
2012. 12.10.2012. Isis Pharma.
2012. 12.12.2012. Eisai
2012. 12.20.2012. Neuro.>ALS Res.
2013. 01.03.2013. Neuro.>ALS Dex.
2013. 04.02. Neuro.>MS>N
2013. 09.09. Neuro.>Isis Pharma.
2013. 12.17. Anti-TNF Biosimilar
2014. 01.09. Sangamo BioSciences
2014. 01.29. Revenues: $6.9B
2014. 02.15. BoD
2014. 03.05. Neuro.>AD
2014. 03.25. MIT>Whitehead Inst.
2014. 03.28. Hemophilia B
2014. 04.30. Neuro.>MS>DiMe
2014. 06.16. Neuro.>MS>Daclizumab
2014. 08.15. Neuro.>MS>PEG IFN
2014. 08.26. ALS Innovation Hub
2014. 08.26. Hemophilia A
2015. 01.08. Neuro.>AON
2015. 01.11. Acq Convergence Pharma
2015. 03.23. Becomes Biogen
2015. 07.02. AGTC
2015. 08.18. Neuro.>ALS
2015. 09.09. Autoimmune Diseases
2016. 01.16. Rheuma.>RA
2016. 05.03. Spin Off Hemophilia
2016. 05.13. Hemophilia B
2016. 05.16. Gene Thera. Uni. Penn.
2016. 07.05. Neuro.>MS>Daclizumab
2016. 08.09. Hemophilia BioVerativ
2016. 12.23. Genetic Dis.>SMA
2017. 01.12. Hemophilia BioVerativ
2017. 01.17. Neuro.>MS>DiMe
2017. 05.15. Acq. Remedy Pharma. s
2017. 05.24. Neuro.>MS>Walk.
2017. 11.27. Neuro.>MS>ALKS 8700
2018. 01.25. Neuro.>Karyopharm
2018. 03.12. Schizophrenia Pfizer
2018. 04.20. Neuro.>Ionis
2018. 06.07. Neuro.>Acute Stroke
2019. 03.04. Acq. Nightstar Therap.
2019. 10.30. Neuro.>MS>Diro>USA>OK
2020. 02.27. Sangamo
2020. 08.06. Neuro.>PD>Denali
2020. 12.21. Neuro.>MS>IM>EU>OK
2021. 01.08. Cevec Pharmaceuticals
2021. 02.01. Neuro.>MS>IM>USA>OK
2021. 04.07. Neuro.>RRMS>EU>OK
2021. 06.07. Neuro.>AD>USA>OK
2021. 07.12. Neuro.>MS>Innocare
2021. 11.16. Neuro.>MS>Diro>EU>OK
2022. 01.04. Ionis
2022. 05.05. MedRhythms Inc
2023. 01.06. Neuro.>AD>USA>OK
2023. 04.25. Neuro.>SOD1-ALS>USA>
2023. 07.28. Acq. Reata Pharma
2023. 08.04. WH>PPD>USA>OK
2023. 09.26. Acq. Reata Pharma
2024. 02.12. Neuro.>FA>EU>OK
Patents
Web-Site
Z - OK

BioGen./P C2's products
This section has no products